OSTX Net Income from 2010 to 2026
| OSTX Stock | 1.18 0.02 1.67% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -8 M | Current Value -8.4 M | Quarterly Volatility 3.9 M |
Check OS Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OS Therapies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 K, Interest Expense of 1.8 M or Selling General Administrative of 4.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.28 or PTB Ratio of 104. OSTX financial statements analysis is a perfect complement when working with OS Therapies Valuation or Volatility modules.
OSTX | Net Income | Build AI portfolio with OSTX Stock |
The evolution of Net Income for OS Therapies Incorporated provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how OS Therapies compares to historical norms and industry peers.
Latest OS Therapies' Net Income Growth Pattern
Below is the plot of the Net Income of OS Therapies Incorporated over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in OS Therapies financial statement analysis. It represents the amount of money remaining after all of OS Therapies Incorporated operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is OS Therapies' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OS Therapies' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (8.88 M) | 10 Years Trend |
|
Net Income |
| Timeline |
OSTX Net Income Regression Statistics
| Arithmetic Mean | (2,753,222) | |
| Coefficient Of Variation | (140.47) | |
| Mean Deviation | 3,555,193 | |
| Median | (6,027) | |
| Standard Deviation | 3,867,435 | |
| Sample Variance | 15T | |
| Range | 8.9M | |
| R-Value | (0.84) | |
| Mean Square Error | 4.7T | |
| R-Squared | 0.71 | |
| Significance | 0.000025 | |
| Slope | (643,269) | |
| Total Sum of Squares | 239.3T |
OSTX Net Income History
Other Fundumenentals of OS Therapies
About OS Therapies Financial Statements
OS Therapies investors use historical fundamental indicators, such as OS Therapies' Net Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in OS Therapies. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.